PURECOAT®
We are Sigachi, a leading name in the world of Microcrystalline Cellulose (MCC) manufacturing tailored for Pharmaceutical applications. With a global footprint spanning over 40 countries, Sigachi has been a trusted supplier for over three decades, earning a reputation among top Pharmaceutical Finished Product manufacturers.
At Sigachi, our extensive manufacturing capabilities have evolved to efficiently address the industry’s growing need for MCC. As your technical partner, we empower you to produce cost-effective, high-quality products with superior performance. Our comprehensive solutions for Solid Oral Dosage Forms cover the entire spectrum from core to coat, with our flagship product, MCC, serving as a reliable diluent/binder.
Our coating offering PureCoat®, a fully formulated ready-mix Film Coating system, adding valuable quality to our portfolio of quality products. PureCoat® comprises meticulously balanced concentrations of polymer, plasticizer, pigments, and opacifiers, ensuring robust and reproducible film coating solutions.
Leveraging Sigachi’s technical expertise, our solutions address batch-to-batch variations, reduce rejections, and enhance overall yields. We are not just providers of materials; we are your partners in success, offering process parameter recommendations, troubleshooting guidance, and on-site demonstrations.
Choose Sigachi for unparalleled quality, reliability, and a commitment to supporting your success in pharmaceutical manufacturing. ”
Ready-to-use Coating Premix: For Pharmaceutical and Nutraceutical Tablet Formulation
FILM COATING SYSTEMS
Ready-to-use innovative and high productivity range of film coating systems for all segments. PureCoat® FCA & FCS is a combination of polymer, plasticizer, opacifier, and glidant.
| Brand name |
Polymer |
Reconstitution |
| PureCoat® FCA-H |
HPMC |
Aqueous and Hydro-alcoholic systems |
| PureCoat® FCS-H |
HPMC |
Non-Aqueous system |
| PureCoat® FCA-P |
PVA |
Aqueous system |
SEAL COATING
Ready-to-use film coating system which protects the core tablet or multiarticulate system from the direct contact with sensitive Active or to protect the dosage from any damages that can cause during the initial spray of Functional coatings, PureCoat® Seal contains a polymer, plasticizer, opacifier (based on the customer’s need), and glidant.
| Brand name |
Polymer |
Reconstitution |
| PureCoat® Seal-H |
HPMC |
Non-Aqueous system |
| PureCoat® Seal-P |
PVA |
Aqueous system |
MOISTURE PROTECTION COATINGS
Ready-to-use film coating systems for moisture-sensitive and hydrophilic pharmaceutical, nutraceutical, and herbal solid oral formulations. PureCoat® MPA and PureCoat® MPS contain polymer, plasticizer, opacifier.
| Brand name |
Polymer |
Reconstitution |
| PureCoat® MPA |
PVA |
Aqueous system |
| PureCoat® MPA-X |
PVA-Xanthan gum |
Aqueous system |
| PureCoat® MPS-P |
HPMC- PEG |
Non-Aqueous and Hydroalcoholic systems |
| PureCoat® MPS-D |
HPMC -Diethyl Phthalate |
Non-Aqueous and Hydroalcoholic systems |
NUTRACEUTICAL COATING
Ready-to-use innovative and high productivity range of film coating systems for Nutraceutical products. PureCoat® Nutra is a combination of polymer, plasticizer, opacifier, and glidant. Titanium dioxide free formulations can be provided for specific requirements.
| Brand name |
Polymer |
Reconstitution |
| PureCoat® Nutra |
HPMC |
Aqueous, Hydro-alcoholic and non-aqueous systems |
| PureCoat® Nutra TDF |
HPMC |
Aqueous system |
| PureCoat® Nutra T2F |
HPMC |
Aqueous system |
DELAYED RELEASE COATINGS
Ready to use Delayed Release/Enteric Film Coating system for Pharmaceutical Dosage forms. PureCoat® ECA and ECS contains Enteric polymer, plasticizer, opacifier, and glidant.
| Brand name |
Polymer |
Reconstitution |
| PureCoat® ECS-A |
MAC (Type A) |
Non-Aqueous system |
| PureCoat® ECS-B |
MAC (Type B) |
Non-Aqueous system |
| PureCoat® ECA-C |
MAC (Type C) |
Aqueous system |
POLYMER BLEND FOR EXTENDED/SUSTAINED RELEASE FORMULATIONS
Optimized Polymer blend for hydrophilic matrices including Hydroxypropyl methylcellulose, Carboxymethyl cellulose sodium, Carbomer. Offering customized solutions specific to the Formulation and target drug release profile and dosage form.
| Name of Grade |
Composition |
Application |
| UltraMod™ SR L |
HPMC and Carboxymethyl cellulose sodium |
Polymer blend that can be used in direct compressible tablet formulation and suitable for low-solubility category of APIs. |
| UltraMod™SR M |
HPMC and Carboxymethyl cellulose sodium |
Polymer blend that can be used for direct compressible tablet formulation and suitable for Medium-solubility category of APIs. |
| UltraMod™ SR H |
HPMC and Carboxymethyl cellulose sodium |
Polymer blend that can be used for directly compressible tablet formulation and suitable for High-solubility category of APIs. |
| UltraMod™ SR LW |
HPMC and Carboxymethyl cellulose sodium |
Polymer blend that can be used in wet granulation process and is suitable for low-solubility category of APIs. |
| UltraMod™ SR MG |
HPMC and Carbomer |
An optimised and ready to use polymer matrix granules to which, choice of APIs, lubricant and Silicon dioxide can be added as per the formula composition followed by compression into tablets. It is suitable of medium solubility category of APIs, especially Diclofenac Sodium. |
| UltraMod™ SR HW |
HPMC and Carboxymethyl cellulose sodium |
Polymer blend that can be used in wet granulation process and is suitable for high-solubility category APIs. |
